| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |